High incidence of secondary brain tumours after radiotherapy and antimetabolites
- 1 July 1999
- journal article
- clinical trial
- Published by Elsevier in The Lancet
- Vol. 354 (9172) , 34-39
- https://doi.org/10.1016/s0140-6736(98)11079-6
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Pharmacogenetics of Cancer Therapy: Getting PersonalAmerican Journal of Human Genetics, 1998
- Conventional Compared with Individualized Chemotherapy for Childhood Acute Lymphoblastic LeukemiaNew England Journal of Medicine, 1998
- p53 gene mutations in pediatric brain tumorsMedical and Pediatric Oncology, 1995
- Second malignant tumors after elective end of therapy for a first cancer in childhood: A multicenter study in ItalyInternational Journal of Cancer, 1994
- Hereditary and acquired p53 gene mutations in childhood acute lymphoblastic leukemia.Journal of Clinical Investigation, 1992
- Second Malignant Neoplasms in Patients Treated for Childhood Leukemia: A Population‐based Cohort Study from the Nordic CountriesActa Paediatrica, 1991
- Altered mercaptopurine metabolism, toxic effects, and dosage requirement in a thiopurine methyltransferase-deficient child with acute lymphocytic leukemiaThe Journal of Pediatrics, 1991
- p53 Mutations in Human CancersScience, 1991
- A Class of $K$-Sample Tests for Comparing the Cumulative Incidence of a Competing RiskThe Annals of Statistics, 1988
- The LancetThe Lancet, 1974